Cancer imaging is an umbrella term that defines diagnostic procedures to identify cancer through imaging – such as scans via x-rays, CT scans and ultrasounds. There is no single imaging test that can accurately diagnose cancer, but a variety of imaging tests can be used in the monitoring of cancer and planning of its treatments.
What is NCITA?
NCITA – the UK National Cancer Imaging Translational Accelerator – is a new consortium that brings together world leading medical imaging experts to create an infrastructure for standardising the cancer imaging process, in order to improve its application in clinical cancer treatment.
Research and medical experts from the University of Oxford have come together with UCL, University of Manchester, the Institute of Cancer Research, Imperial, Cambridge University and many more to create this open access platform.
How will NCITA help cancer research?
On top of bringing together leading experts in cancer imaging to share their knowledge, the NCITA consortium will create a variety of systems, software and facilities to help localise and distribute new research and create a centralised location for cancer-image data to be analysed.
NCITA will in include a data repository for imaging, artificial intelligence (AI) tools and training opportunities – all of which will contributing to a revolution in the speed and accuracy of cancer diagnosis, tumour classification and patient response to treatment.
The NCITA network is led by Prof Shonit Punwani, Prof James O’Connor, Prof Eric Aboagye, Prof Geoff Higgins, Prof Evis Sala, Prof Dow Mu Koh, Prof Tony Ng, Prof Hing Leung and Prof Ruth Plummer with up to 49 co-investigators supporting the NCITA initiative. NCITA is keen to expand and bring in new academic and industrial partnerships as it develops.
Go to the NCITA website to stay up to date of news about cancer imaging research.
For more information on this exciting new initiative, see the media release about the NCITA launch here.